These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16453095)

  • 1. [Antihypertensive drug utilization in obese patients].
    Bramlage P; Bramlage C; Kirch W
    Med Klin (Munich); 2005 Dec; 100(12):804-9. PubMed ID: 16453095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of selected patient's characteristics on the choice of antihypertensive medication in the elderly in Slovakia.
    Wawruch M; Dukat A; Murin J; Wsolova L; Kuzelova M; Macugova A; Wimmer G; Shah R
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1199-205. PubMed ID: 19718707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.
    Maison P; Planchat-Fely P; Vauzelle-Kervroëdan F; Sermet C; Eschwège E
    Diabetes Metab; 2001 Dec; 27(6):661-5. PubMed ID: 11852374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of patients with arterial hypertension in Moscow].
    Iurenev AP; Patrusheva IF; Smirnova MD; Kunnova LM
    Ter Arkh; 2001; 73(9):31-4. PubMed ID: 11642077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys].
    Girerd X; Hanon O; Pannier B; Vaïsse B; Mourad JJ
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):210-4. PubMed ID: 23759733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Queen Mary Utilization of Antihypertensive Drugs Study: side-effects of antihypertensive drugs.
    Cheung BM; Wong YL; Lau CP
    J Clin Pharm Ther; 2005 Aug; 30(4):391-9. PubMed ID: 15985053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.